Literature DB >> 18095060

Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats.

Masafumi Kashii1, Jun Hashimoto, Takayoshi Nakano, Yukichi Umakoshi, Hideki Yoshikawa.   

Abstract

There are safety concerns regarding administration of bisphosphonates to children. Little is known about the effects of bisphosphonates on bone matrix organization during bone modeling. The present study examined the effects of alendronate (ALN) on bone matrices formed by intramembranous ossification in the appendicular growing skeleton. ALN was administered to 1-week-old Sprague-Dawley rats at a dose of 0, 35, or 350 microg/kg/week for 4 or 8 weeks. The position of femoral diaphysis formed exclusively by intramembranous ossification was identified, and cross sections of cortical bone at this position were analyzed. Bone mineral density (BMD) and geometric parameters were evaluated using peripheral quantitative computed tomography. The preferential orientation degree of biological apatite (BAp) crystals in the bone longitudinal direction, which shows the degree of bone matrix anisotropy, was evaluated using microbeam X-ray diffraction analysis. We analyzed bone histomorphometrical parameters and performed bone nanomechanical tests to examine the material properties of newly developing cortical bone. The preferential orientation degree of BAp crystals significantly decreased in 35 microg/kg/week ALN-treated groups compared with vehicle-treated groups, although there were no significant differences in BMD between the two groups. The periosteal mineral apposition rate significantly increased in the 35 microg/kg/week ALN-treated group. We found a high negative correlation between bone matrix anisotropy and the regional periosteal mineral apposition rate (r = -0.862, P < 0.001). Nanomechanical tests revealed that 35 microg/kg/week ALN administration caused deterioration of the material properties of the bone microstructure. These new findings suggest that alendronate affects bone matrix organization and promotes bone formation with a less anisotropic microstructure during intramembranous ossification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095060     DOI: 10.1007/s00774-007-0782-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  51 in total

1.  Unique alignment and texture of biological apatite crystallites in typical calcified tissues analyzed by microbeam X-ray diffractometer system.

Authors:  T Nakano; K Kaibara; Y Tabata; N Nagata; S Enomoto; E Marukawa; Y Umakoshi
Journal:  Bone       Date:  2002-10       Impact factor: 4.398

2.  Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.

Authors:  Naoko Sakagami; Norio Amizuka; Minqi Li; Kiichi Takeuchi; Masaaki Hoshino; Midori Nakamura; Kayoko Nozawa-Inoue; Nobuyuki Udagawa; Takeyasu Maeda
Journal:  Micron       Date:  2005-09-07       Impact factor: 2.251

3.  Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

Authors:  Ken Iwata; Jiliang Li; Helene Follet; Roger J Phipps; David B Burr
Journal:  Bone       Date:  2006-06-27       Impact factor: 4.398

4.  Intrinsic bone tissue properties in adult rat vertebrae: modulation by dietary protein.

Authors:  Stefan Hengsberger; Patrick Ammann; Brian Legros; René Rizzoli; Philippe Zysset
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

5.  Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.

Authors:  B D Baumann; T J Wronski
Journal:  Bone       Date:  1995-02       Impact factor: 4.398

6.  Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.

Authors:  Midori Nakamura; Nobuyuki Udagawa; Sachiko Matsuura; Makio Mogi; Hiroshi Nakamura; Hiroshi Horiuchi; Naoto Saito; B Yukihiro Hiraoka; Yasuhiro Kobayashi; Kunio Takaoka; Hidehiro Ozawa; Hiroo Miyazawa; Naoyuki Takahashi
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

7.  Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.

Authors:  Laura M Gandrud; Jennifer C Cheung; Mark W Daniels; Laura K Bachrach
Journal:  J Pediatr Endocrinol Metab       Date:  2003 Jul-Aug       Impact factor: 1.634

8.  Osteoblast proliferation and maturation by bisphosphonates.

Authors:  Gun-Il Im; Sheeraz A Qureshi; Jennifer Kenney; Harry E Rubash; Arun S Shanbhag
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

Review 9.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

10.  Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.

Authors:  D D Bikle; E R Morey-Holton; S B Doty; P A Currier; S J Tanner; B P Halloran
Journal:  J Bone Miner Res       Date:  1994-11       Impact factor: 6.741

View more
  11 in total

1.  The influence of low-level laser therapy with alendronate irrigation on healing of bone defects in rats.

Authors:  Utkan Kamil Akyol; Sare Sipal; Elif Demirci; Metin Gungormus
Journal:  Lasers Med Sci       Date:  2015-02-17       Impact factor: 3.161

2.  Biomimetic coating of bisphosphonate incorporated CDHA on Ti6Al4V.

Authors:  Huan Zhou; Joseph G Lawrence; Ahmed H Touny; Sarit B Bhaduri
Journal:  J Mater Sci Mater Med       Date:  2011-12-17       Impact factor: 3.896

3.  Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Authors:  Tara L Aghaloo; Ben Kang; Eric C Sung; Michael Shoff; Matthew Ronconi; Jack E Gotcher; Olga Bezouglaia; Sarah M Dry; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

4.  Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates.

Authors:  N Nicolaou; Y Agrawal; M Padman; J A Fernandes; M J Bell
Journal:  J Child Orthop       Date:  2012-01-17       Impact factor: 1.548

5.  Crystallographic orientation of the c-axis of biological apatite as a new index of the quality of subchondral bone in knee joint osteoarthritis.

Authors:  Jee-Wook Lee; Akio Kobayashi; Takayoshi Nakano
Journal:  J Bone Miner Metab       Date:  2016-03-29       Impact factor: 2.626

6.  The Therapeutic Effects of Combination Therapy with Curcumin and Alendronate on Spine Fusion Surgery in the Ovariectomized Rats.

Authors:  Dae-Chul Cho; Kyoungsu Ryu; Kyoung-Tae Kim; Joo-Kyung Sung
Journal:  Korean J Spine       Date:  2017-06-30

7.  Femoral neck fractures in osteogenesis imperfecta treated with bisphosphonates.

Authors:  M C Papanna; S Tafazal; M J Bell; S N Giles; J A Fernandes
Journal:  J Child Orthop       Date:  2017-06-01       Impact factor: 1.548

8.  Live Fluorescent Staining Platform for Drug-Screening and Mechanism-Analysis in Zebrafish for Bone Mineralization.

Authors:  Jung-Ren Chen; Yu-Heng Lai; Jhih-Jie Tsai; Chung-Der Hsiao
Journal:  Molecules       Date:  2017-11-27       Impact factor: 4.411

9.  The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.

Authors:  Ayako Shiraishi; Sayaka Miyabe; Takayoshi Nakano; Yukichi Umakoshi; Masako Ito; Masahiko Mihara
Journal:  BMC Musculoskelet Disord       Date:  2009-06-15       Impact factor: 2.362

10.  Therapeutic advantages of treatment of high-dose curcumin in the ovariectomized rat.

Authors:  Dae-Chul Cho; Hyun-Sik Jung; Kyoung-Tae Kim; Younghoon Jeon; Joo-Kyung Sung; Jeong-Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.